Nanomedicine News

RSS

New Cancer Drug Based on the Use of Photodynamic Therapy to Treat Skin Cancer

A drug that is activated by light can be a quick, simple, and cheap treatment for tens of thousands of patients with skin cancer in Sweden alone. Researcher Leif Eriksson's team at Örebro University in Sweden ha...

20 Nov 2008

Carbon Nanotubes Improving the Limits of Protein Array Detection

To detect cancer as early as possible, dozens of research groups are developing methods to detect trace levels of cancer-related proteins and genes in blood or other biological samples. Those efforts should get a boost thanks to new research results showing that carbon nanotubes can serve as incredibly sensitive optical labels for use in a wide variety of assay systems.

20 Nov 2008

Custom-Designed Nanoparticles Delivering Anticancer Drug Specifically to Prostate Cancer Cells

A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate ...

20 Nov 2008

Multifunctional Nanoparticle Hold Promise for Personalizing Breast Cancer Therapy

One of the hallmarks of many nanoparticle-based anticancer therapeutics and imaging agents is that they accumulate in tumors thanks to the fact that they are small enough to escape from the bloodstream through the leaky ...

20 Nov 2008

Carbon Nanotubes Detect Lung Cancer by Sampling Patient's Breath

Using an array of nanotube devices, each coated with a different organic material, researchers at the Israel Institute of Technology have developed diagnostic system that may be able to diagnose lung cancer simply by sam...

20 Nov 2008

Nanoparticle Targets Melanoma With siRNA

Reporting its findings in the journal Cancer Research, a team of investigators led by Menashe Bar-Eli, Ph.D., Anil Sood, M.D., and Gabriel Lopez-Berestein, M.D., describes its work in designing a neutral liposome nanoparticle to carry its siRNA agent to melanoma cells. Unlike viruses and positively charged liposomes that other investigators have used to deliver siRNA in animal models, the investigators reasoned that neutral liposomes would produce far few adverse reactions while escaping elimination from the body by macrophages.

20 Nov 2008

New Platinum-Phosphate Compounds Can Effectively Kill Ovarian, Testicular, Head and Neck Cancer Cells

A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in ...

20 Nov 2008

IBM Awarded DARPA Funding for Cognitive Computing Collaboration

In an unprecedented undertaking, IBM Research (NYSE: IBM) and five leading universities are partnering to create computing systems that are expected to simulate and emulate the brain's abilities for sensation, perception, action, interaction and cognition while rivaling its low power consumption and compact size.

20 Nov 2008

Invitrogen Announces the Introduction of In Vivo RNAi Delivery Reagent

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine™ delivery reagent which enab...

19 Nov 2008

Sunshine Bio Investments World Launches Funding Initiatives in Nanotechnology Market

Sunshine Bio Investments World, a privately held Canadian company, has established U.S. headquarters in Miami and initiated venture funding for a variety of biotech, pharmaceutical and medical device companies active in ...

19 Nov 2008